期刊文献+

超声骶髂关节检查对强直性脊柱炎诊断作用的Meta分析 被引量:2

Meta-analysis of diagnostic value of sacroiliac joint ultrasound examination in ankylosing spondylitis
下载PDF
导出
摘要 目的应用Meta分析评价超声检查骶髂关节对强直性脊柱炎的诊断价值,为临床诊断提供依据。方法计算机检索PubMed、EMbase、Cochrane Library、中国知网、中国生物医学文献数据库、万方、维普数据库,查找超声检查骶髂关节诊断强直性脊柱炎的诊断性试验,检索时限均为建库至2017年8月1日。由2名研究员按照纳入与排除标准筛选文献、提取数据并采用Revman 5.3工具评价纳入研究的偏倚风险,然后采用Meta-Disc 1.4软件进行Meta分析。结果共纳入5篇文献,包括350例受试者。异质性检验结果提示纳入研究之间存在统计学异质性,采用随机效应模型进行Meta分析。Meta分析结果显示:超声检查骶髂关节诊断强直性脊柱炎的敏感度,特异度,阳性似然比,阴性似然比,诊断比值比分别为0.78(95%CI:0.74~0.82)、0.87(95%CI:0.82~0.91)、5.71(95%CI:3.99~8.15)、0.25(95%CI:0.16~0.39)和27.79(95%CI:11.18~69.06)。SROC曲线下面积为0.9298。结论超声检查骶髂关节是一种较好的诊断强直性脊柱炎的无创检查方法。受纳入研究数量和质量的限制,上述结论尚需要更多研究予以验证。 Objetive To evaluate the diagnostic value of sacroiliac joint ultrasound examination in ankylosing spondylitis(AS) and provide evidence for clinical diagnosis. Methods The databases of Pub Med, EMbase, Cochrane Library,CNKI, China biology medicine disc, wangfang and VIP were retrieved about ultrasound diagnosis test of ultrasonographic examination for AS in sacroiliac joint. The retrieval time from database built to August 1 th, 2017. Two reviewers independently screened and extracted literatures according to inclusion and exclusion criteria. The Revman 5.3 software was applied to assess the risk bias and then Meta-analysis was performed by using Meta-Disc 1.4 software. Results A total of 5 articles involving 350 patients were included. The results of heterogeneity test revealed that there was statistical heterogeneity among the results of the studies, random effects model was adopted for Meta-analysis. The results of Meta-analysis showed that the pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnosis odds ratio for ultrasound checking in sacroiliac joints diagnosis were 0.78(95% CI: 0.74-0.82), 0.87(95% CI:0.82-0.91), 5.71(95%CI: 3.99-8.15), 0.25(95%CI: 0.16-0.39), 27.79(95%CI:11.18-69.06) respectively. The area under the SROC curve was 0.9298. Conclusion Ultrasound in diagnosis of sacroiliac joint in patients with AS is a good non-invasive method as a routine examination. Due to the limited quality and quantity of included samples, the above conclusion is needed to be validated by more high-quality studies.
出处 《中国医药导报》 CAS 2018年第3期64-69,共6页 China Medical Herald
基金 湖北省教育厅重点科研项目(Q20091607) 湖北省中医院科研专项计划项目(JDZX2014Q06) 湖北省中医院科研专项计划项目(JDZX2014Z07)
关键词 超声 强直性脊柱炎 骶髂关节 META分析 诊断性试验 Ultrasound Ankylosing spondylitis Sacroiliac joint Meta-analysis Diagnostic Test
  • 相关文献

参考文献9

二级参考文献98

  • 1彭加友,颜小琼,朱通伯.强直性脊柱炎中西医结合治疗前后影像学对比[J].中国中西医结合影像学杂志,2004,2(3):164-166. 被引量:4
  • 2王庆文,曾庆馀,肖征宇,刘源,陈肃标.磁共振成像对早期骶髂关节炎的诊断价值研究[J].中华风湿病学杂志,2006,10(7):385-388. 被引量:24
  • 3张晓光,朱家安,薛勤,高许萍,简桂花,范瑛,王锋,俞岗,崔勇平,汪年松.彩色超声评估强直性脊柱炎患者附着端血流和声像的特征:病例-对照[J].中国组织工程研究与临床康复,2007,11(23):4577-4579. 被引量:4
  • 4[1]Braz Nogueira J.Regression of left ventricular hypertrophy in hypertension-does it reduce cardiovascular risk?Rev Port Cardiol,2005,24:1007-1013.
  • 5[2]Conrady AO,Rudomanov OG,Zaharov DV,et al.Prospective study of the changes in left ventricular mass and geometry patterns in hypertensive patients During 5 years of follow-up.Circ J,2005,69:1374-1379.
  • 6[3]Okin PM,Devereux RB,Jern S,et al.Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.JAMA,2004,292:2396-2398.
  • 7[4]O'Brien E.Aliskiren:a renin inhibitor offering a new approach for the treatment of hypertension.Expert Opin Investig Drags.2006,15:1269-77.
  • 8[5]Ishani A,Weinhandl E,Zhao Z,et al.Angiotensin-converting enzyme inhibitor as a risk factor for thedevelopment of anemia,and the impact of incident anemia onmortality in patients with left ventricular dysfunction.J AmColl Cardiol,2005,45:391.
  • 9[6]Sugaya,Hw Lju,TX Cui,et al.Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on Vascular injury.Hypertension,2003,42:542-547.
  • 10[7]Jorger R.Kizer,Bjom Dahlof,Sverre E.Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol:the losartan intervention.for endpeint reduction in hypertension study.Hypertension,2005,45:46-52.

共引文献48

同被引文献15

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部